West Pharmaceutical Services | WST - Umlaufvermögen

Aktienkurs
312.55
Täglich Wechseln
2.58 0.83%
Monatlich
20.51%
Jährlich
46.63%
Q2 Prognose
294.43




Umlaufvermögen Veränderung Datum
Align Technology USD 2.66B 38.87M 2026-03
Avanos Medical USD 325M 30.4M 2026-03
Baxter International USD 6.85B 25M 2026-03
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Cerus USD 174.38M 7.26M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
Dentsply International USD 1.85B 178M 2026-03
Haemonetics USD 943.67M 43.99M 2025-12
ICU Medical USD 1.19B 16.74M 2025-12
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.1B 61.62M 2026-03
Neogen USD 590M 15.42M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Quidel USD 1.38B 70.3M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Rockwell Medical USD 31.61M 1.42M 2025-06
Solventum Corp USD 3.58B 276M 2026-03
STAAR Surgical USD 311.54M 9.66M 2025-12
Terumo JPY 815.56B 71.48B 2025-12
Utah Medical Products USD 97.74M 1.21M 2025-12
West Pharmaceutical Services USD 1.83B 151.4M 2026-03